Insights from Avian Influenza: A Review of Its Multifaceted Nature and Future Pandemic Preparedness

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2024 Mar 28

PMID 38543823

Authors

Jianning He

Yiu-Wing Kam

Affiliations

Soon will be listed here.

Abstract

Avian influenza viruses (AIVs) have posed a significant pandemic threat since their discovery. This review mainly focuses on the epidemiology, virology, pathogenesis, and treatments of avian influenza viruses. We delve into the global spread, past pandemics, clinical symptoms, severity, and immune response related to AIVs. The review also discusses various control measures, including antiviral drugs, vaccines, and potential future directions in influenza treatment and prevention. Lastly, by summarizing the insights from previous pandemic control, this review aims to direct effective strategies for managing future influenza pandemics.

Citing Articles

Diagnostic Assays for Avian Influenza Virus Surveillance and Monitoring in Poultry.

Azeem S, Yoon K Viruses. 2025; 17(2).

PMID: 40006983 PMC: 11860460. DOI: 10.3390/v17020228.

Avian Influenza: Outbreak in Viet Nam in 2024.

Patel A, Pal R, Bhowmick M, Mahanty J, Halder P, Ashique S Infect Disord Drug Targets. 2024; 25(1):e280624231376.

PMID: 38952159 DOI: 10.2174/0118715265322184240624074555.

A Retrospective Investigation of a Case of Dual Infection by Avian-Origin Influenza A (H10N5) and Seasonal Influenza A (H3N2) Viruses - Anhui Province, China, December 2023-January 2024.

He J, Gong L, Chen X, Cheng D, Hou S, Kong M China CDC Wkly. 2024; 6(25):605-613.

PMID: 38933038 PMC: 11196879. DOI: 10.46234/ccdcw2024.106.

References

MacMahon K, Delaney L, Kullman G, Gibbins J, Decker J, Kiefer M . Protecting poultry workers from exposure to avian influenza viruses. Public Health Rep. 2008; 123(3):316-22. PMC: 2289984. DOI: 10.1177/003335490812300311. View

van de Sandt C, Kreijtz J, Rimmelzwaan G . Evasion of influenza A viruses from innate and adaptive immune responses. Viruses. 2012; 4(9):1438-76. PMC: 3499814. DOI: 10.3390/v4091438. View

Stegeman A, Bouma A, Elbers A, de Jong M, Nodelijk G, de Klerk F . Avian influenza A virus (H7N7) epidemic in The Netherlands in 2003: course of the epidemic and effectiveness of control measures. J Infect Dis. 2004; 190(12):2088-95. DOI: 10.1086/425583. View

Bouvier N, Palese P . The biology of influenza viruses. Vaccine. 2009; 26 Suppl 4:D49-53. PMC: 3074182. DOI: 10.1016/j.vaccine.2008.07.039. View

Nayak J, Caserta M . Cell-Culture-Based Influenza Vaccines: Don't Put All of Your Influenza Vaccines in the Egg Basket. Pediatrics. 2022; 150(5). DOI: 10.1542/peds.2022-058143. View

Luo M . Influenza virus entry. Adv Exp Med Biol. 2012; 726:201-21. PMC: 7123407. DOI: 10.1007/978-1-4614-0980-9_9. View

Barnett R . Influenza. Lancet. 2019; 393(10170):396. PMC: 7137077. DOI: 10.1016/S0140-6736(19)30148-5. View

Patel M, Chesnokov A, Jones J, Mishin V, De La Cruz J, Nguyen H . Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir. Antiviral Res. 2021; 188:105035. PMC: 8978222. DOI: 10.1016/j.antiviral.2021.105035. View

Hayden F, Shindo N . Influenza virus polymerase inhibitors in clinical development. Curr Opin Infect Dis. 2019; 32(2):176-186. PMC: 6416007. DOI: 10.1097/QCO.0000000000000532. View

10.

Alexander D . An overview of the epidemiology of avian influenza. Vaccine. 2006; 25(30):5637-44. DOI: 10.1016/j.vaccine.2006.10.051. View

11.

van Riet E, Ainai A, Suzuki T, Hasegawa H . Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. Vaccine. 2012; 30(40):5893-900. DOI: 10.1016/j.vaccine.2012.04.109. View

12.

Davis L, Koster F, Cawthon A . Neurologic aspects of influenza viruses. Handb Clin Neurol. 2014; 123:619-45. PMC: 7152431. DOI: 10.1016/B978-0-444-53488-0.00030-4. View

13.

Antinori A, Bausch-Jurken M . The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future. J Infect Dis. 2023; 228(Suppl 1):S4-S12. PMC: 10401620. DOI: 10.1093/infdis/jiad181. View

14.

Yuen K, Chan P, Peiris M, Tsang D, Que T, Shortridge K . Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998; 351(9101):467-71. DOI: 10.1016/s0140-6736(98)01182-9. View

15.

Asha K, Kumar B . Emerging Influenza D Virus Threat: What We Know so Far!. J Clin Med. 2019; 8(2). PMC: 6406440. DOI: 10.3390/jcm8020192. View

16.

Shiraki K, Daikoku T . Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther. 2020; 209:107512. PMC: 7102570. DOI: 10.1016/j.pharmthera.2020.107512. View

17.

Gottlieb T, Ben-Yedidia T . Epitope-based approaches to a universal influenza vaccine. J Autoimmun. 2014; 54:15-20. DOI: 10.1016/j.jaut.2014.07.005. View

18.

Lam J, Baumgarth N . The Multifaceted B Cell Response to Influenza Virus. J Immunol. 2019; 202(2):351-359. PMC: 6327962. DOI: 10.4049/jimmunol.1801208. View

19.

Blagodatski A, Trutneva K, Glazova O, Mityaeva O, Shevkova L, Kegeles E . Avian Influenza in Wild Birds and Poultry: Dissemination Pathways, Monitoring Methods, and Virus Ecology. Pathogens. 2021; 10(5). PMC: 8161317. DOI: 10.3390/pathogens10050630. View

20.

Wang K, Holtz K, Anderson K, Chubet R, Mahmoud W, Cox M . Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine. Vaccine. 2005; 24(12):2176-85. PMC: 7115642. DOI: 10.1016/j.vaccine.2005.11.005. View